Interim results: Moderna vaccine candidate stable and effective
20 November, 2020Interim analysis of Moderna's Phase 3 study of mRNA-1273 finds that the COVID-19 vaccine candidate has an efficacy of 94.5% and remains stable at -20°C for up to six months.
Drug-resistant UTIs: the canary in the coalmine
19 November, 2020One of the world's most common infections will cost Australia more than $1 billion a year within the next decade if nothing is done to stop the rise of antibiotic-resistant bacteria.
Pregnant and postpartum women with COVID-19 are at risk of blood clotting
17 November, 2020 by Amy SarcevicPregnant women who contract COVID-19 may be at higher risk of blood clotting, especially those who become severely ill with the virus, says Associate Professor Sanjaya Senanayake of the Australian National University.
How did Royal Melbourne Hospital curb its COVID-19 outbreak?
16 November, 2020Reported to have endured the largest institutional outbreak of COVID-19 in healthcare workers in Australia, the RMH's multidimensional response has been examined.
Partners take on cancer and heart disease
13 November, 2020GE Healthcare and GenesisCare have partnered to tackle the globe's greatest health burdens: cancer and cardiovascular disease.
Vaccinate potential superspreaders first, researchers say
13 November, 2020Macquarie University researchers have unveiled a strategy that models who should be vaccinated first.
Australian experts respond to Pfizer vaccine announcement
12 November, 2020Pfizer and BioNTech have issued a press release, announcing that their vaccine candidate is more than 90% effective in preventing COVID-19.
Research uncovers the hidden path of breast cancers
11 November, 2020The secret pathway used by some aggressive breast cancers to avoid detection has been uncovered by researchers at Macquarie University.
School poisoning incidence calls for improved safety
09 November, 2020Child and adolescent exposure to poisoning while at school is relatively common and appears to be increasing, according to research from the University of Sydney.
Australia secures two more vaccine candidates
06 November, 2020The Australian Government has secured two more potential coronavirus vaccines for Australia.
Magic mushroom compound holds promise for depression
06 November, 2020The active compound in magic mushrooms — psilocybin — has been found to produce large, rapid and sustained improvements in patients with treatment-resistant major depressive disorder.
Medication safety is everyone's business
05 November, 2020 by Kristin Michaels, SHPA CEOWith the use of medication being the most common healthcare intervention, the challenge of upholding safety has never been more important.
COVID-19 reinfections — what do we know so far?
03 November, 2020 by Amy SarcevicDr Larisa Labzin has helped demystify the topic of COVID-19 reinfections — highlighting what researchers now know for sure, what they think may be true and which areas they still have no idea about.
The critical role of National Critical Care Trauma Response Centre teams
03 November, 2020The COVID-19 pandemic has highlighted the invaluable health work undertaken by the Centre's personnel, who operate as Australian Medical Assistance Teams.
Minimising microplastics release when preparing infant formula
02 November, 2020Discovering that high levels of microplastics are released when preparing formula in polypropylene infant feeding bottles, researchers have developed recommendations to mitigate the risk.
